Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Asthma and nonspecific bronchial hyperreactivity]

R Louis1, J M Kayembe, M F Radermecker

  • 1Service de Pneumologie, CHU Sart Tilman, Liege, Belgique.

Acta Clinica Belgica
|January 1, 1994
PubMed
Summary

Bronchial hyperresponsiveness, a key asthma feature, involves airway smooth muscle and bronchial wall changes. Corticosteroid treatment can effectively reduce this hyperresponsiveness in asthma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma" [Cytokine 202 (2026) 157145].

Cytokine·2026
Same author

Synbiotic Bactecal® reduces airway obstruction, sputum eosinophils and IL-4 but increases sputum IL-8 in patients with uncontrolled asthma.

Cytokine·2026
Same author

Author Correction: Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2026
Same author

Forced oscillation technique in progressive pulmonary fibrosis in a single-center retrospective study.

Scientific reports·2025
Same author

Allergic Rhinitis and its Impact on Asthma (ARIA) Classes in MASK-air Users.

Journal of investigational allergology & clinical immunology·2025
Same author

Increase in Blood Eosinophil Count Over Time and Sputum IL8 are Associated with FEV<sub>1</sub> Decline in Asthma.

Lung·2024

Area of Science:

  • Pulmonology
  • Immunology
  • Pharmacology

Context:

  • Bronchial hyperresponsiveness (BHR) is a defining characteristic of asthma, but also occurs in other respiratory conditions.
  • BHR is influenced by immuno-inflammatory pathways affecting airway smooth muscle function and bronchial wall structure.
  • The correlation between responses to direct pharmacological agents and indirect stimuli in BHR is complex.

Purpose:

  • To explore the multifaceted nature of bronchial hyperresponsiveness.
  • To investigate the relationship between asthma severity and methacholine airway responsiveness.
  • To assess the impact of long-term corticosteroid treatment on BHR.

Summary:

  • BHR is linked to immuno-inflammatory processes impacting airway smooth muscle and bronchial structure.
  • Responsiveness to direct pharmacological agents does not consistently correlate with responses to indirect agents or physical stimuli.
  • Cross-sectional studies indicate a correlation between asthma severity and methacholine airway responsiveness.
  • Long-term corticosteroid therapy has been shown to decrease BHR in individuals with asthma.

Impact:

  • Understanding BHR mechanisms is crucial for asthma management and differential diagnosis.
  • Identifying factors influencing BHR can lead to more targeted therapeutic strategies.
  • This research highlights the potential of corticosteroids in mitigating airway hyperresponsiveness and improving asthma control.

Related Experiment Videos